New drug aims to prevent lifelong lung damage in tiniest newborns
Prevention
Recruiting now
This study tests an investigational drug, zelpultide alfa, to see if it can prevent a serious lung condition called bronchopulmonary dysplasia (BPD) in extremely premature babies (born as early as 22 weeks). About 366 high-risk infants who are on breathing machines will receive e…
Phase: PHASE2, PHASE3 • Sponsor: Airway Therapeutics, Inc. • Aim: Prevention
Last updated May 26, 2026 11:28 UTC